ENOV Insider Trading

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Enovis Insider Trading History Chart

This chart shows the insider buying and selling history at Enovis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Enovis Share Price & Price History

Current Price: $34.67
Price Change: Price Decrease of -0.43 (-1.23%)
As of 04/28/2025 04:59 PM ET

This chart shows the closing price history over time for ENOV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$34.67Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Enovis (NYSE:ENOV)

98.45% of Enovis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ENOV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$23Mbought$6.26MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400M-$200M$0$200M$400MTotal InflowsTotal Outflows
Enovis logo
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Read More on Enovis

Today's Range

Now: $34.67
Low: $34.34
High: $35.54

50 Day Range

MA: $36.51
Low: $30.60
High: $44.55

52 Week Range

Now: $34.67
Low: $29.32
High: $56.43

Volume

1,104,537 shs

Average Volume

750,302 shs

Market Capitalization

$1.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Enovis?

Enovis' top insider investors include:
  1. Phillip Benjamin (Ben) Berry (CFO)
  2. Rajiv Vinnakota (Director)
  3. John Kleckner (Insider)
Learn More about top insider investors at Enovis.

Who are the major institutional investors of Enovis?

Enovis' top institutional shareholders include:
  1. DAVENPORT & Co LLC — 5.38%
  2. Artemis Investment Management LLP — 1.22%
  3. Principal Financial Group Inc. — 0.49%
  4. Allspring Global Investments Holdings LLC — 0.49%
  5. Lawson Kroeker Investment Management Inc. NE — 0.37%
  6. Wedge Capital Management L L P NC — 0.29%
Learn More about top institutional investors of Enovis stock.

Which major investors are selling Enovis stock?

In the last quarter, ENOV stock was sold by these institutional investors:
  1. KBC Group NV
  2. Rhumbline Advisers
  3. Allspring Global Investments Holdings LLC
  4. Wedge Capital Management L L P NC
  5. Envestnet Portfolio Solutions Inc.
  6. Amalgamated Bank
  7. Confluence Investment Management LLC
  8. Oppenheimer Asset Management Inc.

Which major investors are buying Enovis stock?

Within the previous quarter, ENOV stock was acquired by institutional investors including:
  1. DAVENPORT & Co LLC
  2. Principal Financial Group Inc.
  3. Central Valley Advisors LLC
  4. GAMMA Investing LLC
  5. Artemis Investment Management LLP
  6. Illinois Municipal Retirement Fund
  7. State of Alaska Department of Revenue
  8. Institute for Wealth Management LLC.